Angie Bell, the member for McPherson, voiced the frustration. “On the health technology assessment review, we haven't really seen any movement either. The release of the review was delayed. People are somewhat over reviews. We need to see action now.”
Coalition turns debate on cheaper medicines Bill to HTA reform delays
August 27, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Coalition turns debate on cheaper medicines Bill to HTA reform delays
August 27, 2025 - - Latest News -
Pharmacy Guild showcases more accessible healthcare for women
August 27, 2025 - - Latest News -
Sandoz pushes for biosimilar reform while building a great workplace
August 27, 2025 - - Latest News -
Cartherics secures Chinese patent to boost immune cell function in solid tumours
August 27, 2025 - - Australian Biotech -
NeuroScientific’s StemSmart MSC therapy shows promise in kidney transplantation
August 27, 2025 - - Australian Biotech -
Starpharma advances dendrimer platform with clinical, commercial, and strategic progress
August 27, 2025 - - Australian Biotech -
Biome achieves breakthrough year with first profit and rapid global expansion
August 27, 2025 - - Australian Biotech